The Growing Demand for Natural and Organic Products Is Driving Aromatherapy Market Growth


Aromatherapy Market, by Product Type (Consumables (Essential Oils (Singles (Herbaceous, Woody, Spicy, Floral, Citrus, Earthy, Camphoraceous, and Others), Blends (Carrier Oils)) and Equipment (Ultrasonic, Nebulizing, Evaporative, and Heat)), by Application (Skin & Hair Care, Pain Management, Insomnia, Boosting Immunity, Scar Management, and Others), by Mode of Delivery (Topical Application, Direct Inhalation, and Aerial Diffusion), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Market Overview:

Aromatherapy is a holistic healing practice that uses the essential oils of plants to promote physical, emotional, and spiritual well-being. Essential oils are highly concentrated extracts that are derived from different parts of plants, such as flowers, leaves, roots and stems. These oils are believed to have therapeutic properties that can affect the body and mind when inhaled or applied to the skin.

Aromatherapy is typically used in conjunction with other holistic practices, such as massage, meditation, and yoga, to enhance their therapeutic benefits. It is used to alleviate a wide range of physical and emotional conditions, including stress, anxiety, depression, pain, and inflammation.

Competitive Landscape:

Major players operating in the global Aromatherapy Market include Isagenix International LLC., RyohinKeikaku Co. Ltd, Ouwave Aroma Tech Co. Ltd, G Baldwin & Co., Thann-Oryza Co. Ltd, Plant Therapy Inc., Mountain Rose Herbs, Rocky Mountain Oil, Frontier Natural Products Corporation, Young Living Essential Oils, Eden Garden, Symrise, International Flavors & Fragrances Inc., Koninklijke DSM N.V., and doTERRA International.

Key Market Drivers:

Growing demand for natural and organic products and increasing awareness about the benefits of essential oils is expected to augment the growth of the global market for aromatherapy. For instance, according to the World health Organization, around 1.71 billion individuals suffer from musculoskeletal conditions globally.

The global Aromatherapy Market was valued at $1.3 billion in 2020 and is expected to reach $2.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period.

Moreover, the rising prevalence of stress-related disorders, growing popularity of aromatherapy in spas and wellness centers, and advancements in extraction technologies are also estimated to enhance the growth of the global market for aromatherapy.

Covid-19 Impact Analysis:

The COVID-19 pandemic has had a mixed impact on the global Aromatherapy Market. On the one hand, the pandemic has increased the demand for essential oils as people seek to manage stress and anxiety caused by the pandemic. On the other hand, the lockdowns and restrictions on travel have affected the supply chain of essential oils, leading to supply shortages and price fluctuations. However, as the world recovers from the pandemic, the demand for aromatherapy is expected to continue to grow.

Key Takeaways:

· North America is expected to dominate the growth of the global market for aromatherapy, owing to the high adoption of aromatherapy in the region. For instance, according to the National Institutes of Health (NIH), around 23.4 million adults suffer from body pain in the United States.

· The Asia Pacific region is estimated to witness high growth in the global Aromatherapy Market, owing to the increasing adoption of aromatherapy in countries like China and India. For instance, in February 2023, Zed Black, India launched a new range of Zed Black launches range of pure essentials oils, called the Orva Naturals.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more